Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p723 has 109 genes in the original annotation. Currently, there are 80 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
983	CDK1	CDC2 \| CDC28A \| P34CDC2	cyclin-dependent kinase 1	10q21.1
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
8038	ADAM12	ADAM12-OT1 \| CAR10 \| MCMP \| MCMPMltna \| MLTN \| MLTNA	ADAM metallopeptidase domain 12	10q26
161	AP2A2	ADTAB \| CLAPA2 \| HIP-9 \| HIP9 \| HYPJ	adaptor related protein complex 2 alpha 2 subunit	11p15.5
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
6199	RPS6KB2	KLS \| P70-beta \| P70-beta-1 \| P70-beta-2 \| S6K-beta2 \| S6K2 \| SRK \| STK14B \| p70(S6K)-beta \| p70S6Kb	ribosomal protein S6 kinase B2	11q13.2
867	CBL	C-CBL \| CBL2 \| FRA11B \| NSLL \| RNF55	Cbl proto-oncogene, E3 ubiquitin protein ligase	11q23.3
3709	ITPR2	ANHD \| CFAP48 \| INSP3R2 \| IP3R2	inositol 1,4,5-trisphosphate receptor type 2	12p11
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
3164	NR4A1	GFRP1 \| HMR \| N10 \| NAK-1 \| NGFIB \| NP10 \| NUR77 \| TR3	nuclear receptor subfamily 4 group A member 1	12q13
112	ADCY6	AC6 \| LCCS8	adenylate cyclase 6	12q13.12
4193	MDM2	ACTFS \| HDMX \| hdm2	MDM2 proto-oncogene	12q14.3-q15
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
10253	SPRY2	IGAN3 \| hSPRY2	sprouty RTK signaling antagonist 2	13q31.1
801	CALM1	CALML2 \| CAMI \| CPVT4 \| DD132 \| LQT14 \| PHKD \| caM	calmodulin 1 (phosphorylase kinase, delta)	14q32.11
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
3320	HSP90AA1	EL52 \| HEL-S-65p \| HSP86 \| HSP89A \| HSP90A \| HSP90N \| HSPC1 \| HSPCA \| HSPCAL1 \| HSPCAL4 \| HSPN \| Hsp89 \| Hsp90 \| LAP-2 \| LAP2	heat shock protein 90kDa alpha family class A member 1	14q32.33
102	ADAM10	AD10 \| AD18 \| CD156c \| CDw156 \| HsT18717 \| MADM \| RAK \| kuz	ADAM metallopeptidase domain 10	15q22
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
1445	CSK	-	c-src tyrosine kinase	15q24.1
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
64223	MLST8	GBL \| GbetaL \| LST8 \| POP3 \| WAT1	MTOR associated protein, LST8 homolog	16p13.3
7249	TSC2	LAM \| PPP1R160 \| TSC4	tuberous sclerosis 2	16p13.3
115	ADCY9	AC9 \| ACIX	adenylate cyclase 9	16p13.3
113	ADCY7	AC7	adenylate cyclase 7	16q12.1
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
5573	PRKAR1A	ACRDYS1 \| ADOHR \| CAR \| CNC \| CNC1 \| PKR1 \| PPNAD1 \| PRKAR1 \| TSE1	protein kinase cAMP-dependent type I regulatory subunit alpha	17q24.2
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
9146	HGS	HRS	hepatocyte growth factor-regulated tyrosine kinase substrate	17q25
11140	CDC37	P50CDC37	cell division cycle 37	19p13.2
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
2931	GSK3A	-	glycogen synthase kinase 3 alpha	19q13.2
808	CALM3	HEL-S-72 \| PHKD \| PHKD3	calmodulin 3 (phosphorylase kinase, delta)	19q13.2-q13.3
29924	EPN1	-	epsin 1	19q13.42
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
5567	PRKACB	PKA C-beta \| PKACB	protein kinase cAMP-activated catalytic subunit beta	1p31.1
998	CDC42	CDC42Hs \| G25K \| TKS	cell division cycle 42	1p36.1
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
57761	TRIB3	C20orf97 \| NIPK \| SINK \| SKIP3 \| TRB3	tribbles pseudokinase 3	20p13-p12.2
6714	SRC	ASV \| SRC1 \| c-SRC \| p60-Src	SRC proto-oncogene, non-receptor tyrosine kinase	20q12-q13
5335	PLCG1	NCKAP3 \| PLC-II \| PLC1 \| PLC148 \| PLCgamma1	phospholipase C gamma 1	20q12-q13.1
7529	YWHAB	GW128 \| HEL-S-1 \| HS1 \| KCIP-1 \| YWHAA	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	20q13.1
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
5581	PRKCE	PKCE \| nPKC-epsilon	protein kinase C epsilon	2p21
805	CALM2	CAMII \| LQT15 \| PHKD \| PHKD2 \| caM	calmodulin 2 (phosphorylase kinase, delta)	2p21
109	ADCY3	AC-III \| AC3	adenylate cyclase 3	2p23.3
6868	ADAM17	ADAM18 \| CD156B \| CSVP \| NISBD \| NISBD1 \| TACE	ADAM metallopeptidase domain 17	2p25
10254	STAM2	Hbp \| STAM2A \| STAM2B	signal transducing adaptor molecule 2	2q23.3
5136	PDE1A	CAM-PDE-1A \| HCAM-1 \| HCAM1 \| HSPDE1A	phosphodiesterase 1A	2q32.1
1385	CREB1	CREB \| CREB-1	cAMP responsive element binding protein 1	2q34
26018	LRIG1	LIG-1 \| LIG1	leucine-rich repeats and immunoglobulin-like domains 1	3p14
5576	PRKAR2A	PKR2 \| PRKAR2	protein kinase cAMP-dependent type II regulatory subunit alpha	3p21.3-p21.2
5580	PRKCD	ALPS3 \| CVID9 \| MAY1 \| PKCD \| nPKC-delta	protein kinase C delta	3p21.31
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
1173	AP2M1	AP50 \| CLAPM1 \| mu2	adaptor related protein complex 2 mu 1 subunit	3q28
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
10252	SPRY1	hSPRY1	sprouty RTK signaling antagonist 1	4q28.1
2549	GAB1	-	GRB2 associated binding protein 1	4q31.21
253260	RICTOR	AVO3 \| PIA \| hAVO3	RPTOR independent companion of MTOR, complex 2	5p13.1
108	ADCY2	AC2 \| HBAC2	adenylate cyclase 2 (brain)	5p15.3
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
814	CAMK4	CaMK IV \| CaMK-GR \| IV \| caMK	calcium/calmodulin-dependent protein kinase IV	5q21.3
3710	ITPR3	IP3R \| IP3R3	inositol 1,4,5-trisphosphate receptor type 3	6p21
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
2309	FOXO3	AF6q21 \| FKHRL1 \| FKHRL1P2 \| FOXO2 \| FOXO3A	forkhead box O3	6q21
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
107	ADCY1	AC1 \| DFNB44	adenylate cyclase 1 (brain)	7p12.3
5575	PRKAR1B	PRKAR1	protein kinase cAMP-dependent type I regulatory subunit beta	7p22
5577	PRKAR2B	PRKAR2 \| RII-BETA	protein kinase cAMP-dependent type II regulatory subunit beta	7q22
55824	PAG1	CBP \| PAG	phosphoprotein membrane anchor with glycosphingolipid microdomains 1	8q21.13
114	ADCY8	AC8 \| ADCY3 \| HBAC1	adenylate cyclase 8 (brain)	8q24
1211	CLTA	LCA	clathrin light chain A	9p13
5568	PRKACG	BDPLT19 \| KAPG \| PKACg	protein kinase cAMP-activated catalytic subunit gamma	9q13
30011	SH3KBP1	CD2BP3 \| CIN85 \| GIG10 \| HSB-1 \| HSB1 \| MIG18	SH3-domain kinase binding protein 1	Xp22.1-p21.3